Measuring the magnetization of various alloys in the Ni3Al and Ni3Ga phases, we found that going to higher Ni concentrations within these phases, a transition from strongly exchange enhanced paramagnetism to weak ferromagnetism takes place at 74.5 and 76 at.% Ni, respectively. The shape of the reciprocal magnetic susceptibility vs temperature curves measured between 4.2° and 300°K is of the Stoner type and suggests for these alloys a density-of-states curve varying appreciably in the Fermi region leading to a low effective Fermi energy. This conclusion is confirmed by the strong curvature of the magnetization in high magnetic fields. These results and the fact that an increase of the magnetic field applied on ferro-magnetic samples effects a large increase of the magnetization even at the lowest temperatures (4.2°K) and in the highest fields (200 kOe) led us to a description in terms of the itinerant electron model. The use of this model seems justified by the fact that in agreement with calculations by Edwards and Wohlfarth, the magnetic data of both paramagnetic and ferromagnetic compositions fit nicely on straight lines in σ2 vs H/σ plots, this being so for all temperatures (down to 4.2°K) and all magnetic fields between 4 and 200 kOe. Combining the magnetic data and low-temperature specific-heat data, we obtained some information on the bandshape at the Fermi level. We cannot conclude, however, to more than a nice qualitative agreement with the Stoner model at this moment. As would be expected in highly polarizable metals and alloys, small amounts of Fe dissolved both in paramagnetic and in ferromagnetic alloys in the Ni3Al and Ni3Ga phases lead to giant moment inducement.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.